Cargando…
Loss to follow-up in “test and treat era” and its predictors among HIV-positive adults receiving ART in Northwest Ethiopia: Institution-based cohort study
BACKGROUND: People living with HIV/AIDS are enrolled in lifelong Anti-Retroviral Treatment (ART) irrespective of their clinical staging as well as CD4 cell count. Although this “Universal Test and Treat” strategy of ART was found to have numerous benefits, loss from follow-up and poor retention rema...
Autores principales: | Bantie, Berihun, Seid, Awole, Kerebeh, Gashaw, Alebel, Animut, Dessie, Getenet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557930/ https://www.ncbi.nlm.nih.gov/pubmed/36249247 http://dx.doi.org/10.3389/fpubh.2022.876430 |
Ejemplares similares
-
Delayed ART initiation in “Test and Treat era” and its associated factors among adults receiving antiretroviral therapy at public health institutions in Northwest Ethiopia: A multicenter cross-sectional study
por: Bantie, Berihun, et al.
Publicado: (2022) -
Attrition rate and its predictors among adults receiving anti-retroviral therapy following the implementation of the “Universal Test and Treat strategy” at public health institutions in Northern Ethiopia. A retrospective follow-up study
por: Bantie, Berihun, et al.
Publicado: (2022) -
Incidence and predictors of initial antiretroviral therapy regimen change among children in public health facilities of Bahir Dar City, Northwest Ethiopia, 2021: multicenter retrospective follow-up study
por: Azmeraw, Molla, et al.
Publicado: (2022) -
Time to Death and Predictors Among Neonates with Esophageal Atresia in Ethiopia
por: Misganaw, Natnael Moges, et al.
Publicado: (2022) -
Incidence and predictors of hyperglycemic emergencies among adult diabetic patients in Bahir Dar city public hospitals, Northwest Ethiopia, 2021: A multicenter retrospective follow-up study
por: Abate, Melsew Dagne, et al.
Publicado: (2023)